The company maintains a vulnerable capital structure with a current ratio of 1.12 and a debt-to-equity ratio of 0.65, leaving limited flexibility for operational pivots.
| Metric | TTM | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Aug'14 | Aug'13 | Aug'12 | Aug'11 | Aug'10 | Aug'09 | Aug'08 | Aug'07 |
|---|
| Total Current Assets | 67.33M | 79.18M | 61.89M | 72.83M | 59.93M | 105.23M | 75.42M | 15.43M | 9.47M | 3.03M | 10.12M | 8.08M | 3.3M | 1.86K | 186 | 4.23K | 1.72K | 13.87K | 37.81K | 23.36K |
| Cash & Short-Term Investments | 26.71M | 30.95M | 20.01M | 22.98M | 19.36M | 49.65M | 48.08M | 11.04M | 7.01M | 802.33K | 9.1M | 7.35M | 2.64M | 1.86K | 109 | 3.99K | 1.54K | 13.61K | 37.64K | 23.36K |
| Cash Only | 26.71M | 30.95M | 20.01M | 22.98M | 19.36M | 49.65M | 48.08M | 11.04M | 7.01M | 802.33K | 8.05M | 7.35M | 2.64M | 1.86K | 109 | 3.99K | 1.54K | 13.61K | 37.64K | 23.36K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 24.49M | 31.16M | 23.53M | 28.94M | 21.71M | 28.18M | 5.63M | 1.74M | 578.78K | 528.04K | 162.43K | 157.06K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 193.13 | 171.31 | 131.74 | 98.34 | 81.98 | 156.7 | 74.41 | 86.8 | 57.72 | 59.83 | 23.14 | 218.98 | - | - | - | - | - | - | - | - |
| Inventory | 7.46M | 11.43M | 12.14M | 11.99M | 10.85M | 16.34M | 10M | 1.44M | 1.34M | 1.31M | 524.71K | 39.44K | 10.45K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 161.88 | 203.08 | 274.75 | 107.4 | 85.37 | 163.69 | 440.72 | 238.7 | 238.34 | 337.93 | 200.11 | 163.39 | - | - | - | - | - | - | - | - |
| Other Current Assets | 8.66M | 0 | 1.12M | 868K | 633K | 1.29M | 5.99M | 250K | 100K | 75.21K | 121.98K | 163.41K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 44.36M | 45M | 56.97M | 65.01M | 77.69M | 160.43M | 77.87M | 19.29M | 11.59M | 11.97M | 14.22M | 10.14M | 8.71M | 7.81K | 12.46K | 18.61K | 25.37K | 27.98K | 36.27K | 36.31K |
| Property, Plant & Equipment | 1.32M | 1.59M | 1.52M | 3.87M | 6.3M | 8.7M | 893K | 203.73K | 219K | 647.25K | 231.43K | 30K | 57K | 7.52K | 12.46K | 18.61K | 25.37K | 27.98K | 36.27K | 36.31K |
| Fixed Asset Turnover | 38.61x | 41.67x | 42.83x | 27.76x | 15.35x | 7.54x | 30.94x | 35.93x | 16.71x | 4.98x | 11.07x | 8.73x | 1.03x | 0.23x | 0.14x | - | - | 0.06x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 65.8M | 28.09M | 0 | 0 | 238.43K | 221K | 74K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 42.49M | 42.2M | 52.45M | 58.97M | 70.63M | 85.46M | 48.85M | 19.08M | 11.37M | 11.08M | 13.55M | 9.7M | 8.2M | 770.35K | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | -10.91M | 0 | 0 | 0 | 0 | 0 | -41.43K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 556K | 1.2M | 2.23M | 792K | 766K | 465K | 33K | 2.2K | 4.72K | 2.89K | 216.36K | 339.82K | 457.25K | -770.06K | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 111.69M | 124.18M | 118.86M | 137.84M | 137.62M | 265.67M | 153.29M | 34.72M | 21.06M | 15M | 24.34M | 18.23M | 12.02M | 9.67K | 12.65K | 22.84K | 27.09K | 41.85K | 74.07K | 59.67K |
| Asset Turnover | 0.47x | 0.53x | 0.55x | 0.78x | 0.70x | 0.25x | 0.18x | 0.21x | 0.17x | 0.21x | 0.11x | 0.01x | 0.00x | 0.18x | 0.14x | - | - | 0.04x | - | - |
| Asset Growth % | 7.27% | 4.48% | -13.77% | 0.16% | -48.2% | 73.31% | 341.49% | 64.87% | 40.41% | -38.39% | 33.56% | 51.69% | 124174.48% | -23.55% | -44.62% | -15.7% | -35.27% | -43.5% | 24.13% | - |
| Total Current Liabilities | 59.97M | 63.06M | 62.23M | 69.02M | 64.44M | 109.44M | 28.76M | 5.37M | 3.39M | 3.61M | 10.1M | 1.48M | 6.09M | 120.53K | 82.36K | 58.43K | 82.7K | 55.44K | 48.12K | 40.87K |
| Accounts Payable | 13.21M | 10.6M | 10.31M | 13.48M | 10.99M | 19.25M | 11.64M | 2.13M | 2.12M | 2.22M | 2.32M | 1.2M | 310 | 6.84K | 5.84K | 330 | 477 | 0 | 0 | 1.74K |
| Days Payables Outstanding | 216.77 | 188.28 | 233.41 | 120.67 | 86.45 | 192.91 | 513.05 | 353.64 | 377.3 | 571.8 | 885.77 | 4.95K | - | -51.76 | - | - | - | - | - | - |
| Short-Term Debt | 12.47M | 10.92M | 4.96M | 8.74M | 3.81M | 24.6M | 982K | 0 | 0 | 0 | 0 | 0 | 30.98K | 99.51K | 68.05K | 52.3K | 77.6K | 54.62K | 48.12K | 34.4K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 57.23M | 339.34K | 0 | 0 | 0 | 0 | 85.71K | 85.71K | 264.17K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 34.29M | 26.14M | 42.35M | 41.12M | 23.84M | 1.47M | 8M | 2.23M | 734.43K | 1.05M | 6.58M | 1.45K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 1.12x | 1.26x | 0.99x | 1.06x | 0.93x | 0.96x | 2.62x | 2.87x | 2.79x | 0.84x | 1.00x | 5.47x | 0.54x | 0.02x | 0.00x | 0.07x | 0.02x | 0.25x | 0.79x | 0.57x |
| Quick Ratio | 1.00x | 1.07x | 0.80x | 0.88x | 0.76x | 0.81x | 2.27x | 2.60x | 2.40x | 0.48x | 0.95x | 5.44x | 0.54x | 0.02x | 0.00x | 0.07x | 0.02x | 0.25x | 0.79x | 0.57x |
| Cash Conversion Cycle | 138.24 | 186.1 | 173.08 | 85.07 | 80.89 | 127.48 | 2.08 | -28.15 | -81.25 | -174.05 | -662.53 | -4.57K | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 16.57M | 42.15M | 28.91M | 29.47M | 28.87M | 18.66M | 29.52M | 22.26M | 4.24M | 7.39M | 4.15M | 1.13M | 554.41K | 0 | 73.9K | 52.63K | 78.08K | 54.62K | 48.12K | 36.14K |
| Long-Term Debt | 9.55M | 10.89M | 10.88M | 20.86M | 14.2M | 2.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 2.88M | 985K | 577K | 832K | 84K | 2.62M | 725K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 762K | 1.38M | 0 | 11.15M | 0 | 0 | 0 | 0 | 0 | 41.43K | 42.81K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 6.11M | 30.27M | 16.7M | 6.4M | 14.59M | 13.23M | 28.79M | 22.26M | 4.24M | 7.39M | 4.15M | 664K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 76.55M | 105.21M | 91.14M | 98.48M | 93.31M | 128.1M | 58.28M | 27.63M | 7.64M | 11M | 14.26M | 2.61M | 6.65M | 120.53K | 82.36K | 58.43K | 82.7K | 55.44K | 48.12K | 40.87K |
| Total Debt | 22.94M | 22.94M | 16.42M | 30.43M | 18.19M | 30.97M | 2.01M | 0 | 0 | 0 | 0 | 0 | 4.6M | 99.51K | 68.05K | 52.3K | 77.6K | 54.62K | 48.12K | 34.4K |
| Net Debt | -3.78M | -8.02M | -3.59M | 7.44M | -1.17M | -18.68M | -46.08M | -11.04M | -7.01M | -802.33K | -8.05M | -7.35M | 1.96M | 97.65K | 67.94K | 48.31K | 76.05K | 41K | 10.47K | 11.04K |
| Debt / Equity | 0.65x | 1.21x | 0.59x | 0.77x | 0.41x | 0.23x | 0.02x | - | - | - | - | - | 0.86x | - | - | - | - | - | 1.85x | 1.83x |
| Debt / EBITDA | -2.07x | - | 3.20x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 0.34x | - | -0.70x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -13.52x | -2.71x | -1.11x | -2.44x | -0.26x | - | - | - | -23.81x | -7.88x | -4.13x | -66.37x | -13.58x | -10.69x | -16.98x | -41.98x | -14.85x | -18.17x | - | -22.72x |
| Total Equity | 35.14M | 18.97M | 27.72M | 39.36M | 44.31M | 137.57M | 95.02M | 7.09M | 13.42M | 4M | 10.09M | 15.62M | 5.37M | -110.86K | -69.72K | -35.59K | -55.61K | -13.58K | 25.96K | 18.81K |
| Equity Growth % | -107.02% | -31.57% | -29.58% | -11.17% | -67.79% | 44.79% | 1240.54% | -47.2% | 235.63% | -60.34% | -35.42% | 190.84% | 4943.59% | -59.01% | -95.86% | 35.99% | -309.39% | -152.33% | 38.03% | - |
| Book Value per Share | 3.34 | 3.02 | 5.00 | 11.78 | 30.14 | 163.77 | 413.11 | 181.87 | 4033.78 | 34331.42 | 463368.52 | 999999.00 | 596600.78 | -13857.00 | -8714.75 | -4449.38 | -9268.00 | -2716.60 | 5191.60 | - |
| Total Shareholders' Equity | 35.14M | 18.97M | 27.72M | 39.36M | 44.31M | 137.57M | 95.02M | 7.09M | 13.42M | 4M | 10.09M | 15.62M | 5.37M | -110.86K | -69.72K | -35.59K | -55.61K | -13.58K | 25.96K | 18.81K |
| Common Stock | 1K | 1K | 1K | 1K | 0 | 3K | 1K | 1.75K | 179 | 82 | 374 | 1.43K | 790 | 414.03K | 0 | 0 | 1K | 0 | 205.25K | 0 |
| Retained Earnings | -347.77M | -333.54M | -319.97M | -304.13M | -287.08M | -178.3M | -120.01M | -106.39M | -79.26M | -69.07M | -46.56M | -18.38M | -10.66M | -568.7K | -500 | -500 | -500 | -254.14K | -195.75K | -138.57K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -246K | -112K | -5M | -33K | 10.47M | -510.89K | -451.21K | -314.41K | -1.26K | 449 | 417 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Persistent capital erosion
As reported in recent financial statements, AYTU's equity base has contracted significantly from $32.9M in 2024Q2 to $35.1M in 2026Q3, with a peak of $14.2M in 2026Q2, indicating that persistent operating losses are systematically consuming the company's net asset value over time.
The consistent decline in retained earnings, which have deepened to -$347.8M, suggests that the company's core business model is failing to generate sufficient returns to offset its operational footprint. Investors should monitor this trajectory, as the continued depletion of equity may necessitate future dilutive financing to maintain basic solvency.
Based on the company's reported figures, goodwill remains a substantial component of the $111.7M total asset base at $42.5M, suggesting that a significant portion of the balance sheet is tied to historical acquisitions rather than tangible, productive assets like the $1.3M in net PPE.
The heavy reliance on intangible assets implies that the company's book value is highly sensitive to impairment charges if the ADHD portfolio fails to meet performance expectations. This asset mix highlights a business model that is structurally dependent on the long-term viability of acquired intellectual property rather than physical manufacturing scale.
According to recent SEC filings, AYTU's current ratio has fluctuated near the 1.0x threshold, reaching 1.12 in 2026Q3, which indicates a limited margin of safety for meeting short-term obligations given the company's ongoing cash burn and lack of consistent operating cash flow.
The proximity of the current ratio to unity suggests that the company operates with minimal working capital cushion, leaving it vulnerable to any unexpected disruptions in revenue or delays in collections. This liquidity profile warrants close scrutiny, as the firm appears to have little room to absorb operational shocks without further depleting its cash reserves.
Analysis of the provided financial data reveals that goodwill accounts for approximately 38% of total assets as of 2026Q3, which may be misleadingly optimistic given the company's persistent operating losses and the competitive pressures facing its primary ADHD product lines.
The persistence of high goodwill levels despite a contracting revenue base suggests that the company may be deferring necessary impairment charges that would otherwise further erode its already thin equity position. Investors should consider the possibility that the carrying value of these intangibles does not reflect current market realities or the actual cash-generating potential of the underlying assets.
Quick answers to the most common questions about buying AYTU stock.
As of 2025, Aytu BioPharma, Inc. (AYTU) had total assets of $124.2M including $79.2M in current assets.
Aytu BioPharma, Inc. (AYTU) carries total debt of $22.9M, offset by $31.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Aytu BioPharma, Inc. (AYTU) has total shareholders' equity (book value) of $19.0M ($3.02 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Aytu BioPharma, Inc. (AYTU) reported a current ratio of 1.26x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.